AN2 Therapeutics, Inc. (ANTX)
5.74
-0.24
(-4.01%)
USD |
NASDAQ |
Sep 09, 11:41
AN2 Therapeutics 1 Year Total Returns (Daily) : 402.5% for Sept. 8, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 08, 2026 | 402.5% |
| September 04, 2026 | 367.5% |
| September 03, 2026 | 361.2% |
| September 02, 2026 | 417.4% |
| September 01, 2026 | 398.2% |
| August 31, 2026 | 404.5% |
| August 28, 2026 | 407.3% |
| August 27, 2026 | 403.5% |
| August 26, 2026 | 380.9% |
| August 25, 2026 | 403.1% |
| August 24, 2026 | 389.6% |
| August 21, 2026 | 423.4% |
| August 20, 2026 | 417.0% |
| August 19, 2026 | 418.3% |
| August 18, 2026 | 433.0% |
| August 17, 2026 | 435.5% |
| August 14, 2026 | 467.8% |
| August 13, 2026 | 469.5% |
| August 12, 2026 | 498.1% |
| August 11, 2026 | 459.0% |
| August 10, 2026 | 447.2% |
| August 07, 2026 | 449.1% |
| August 06, 2026 | 465.6% |
| August 05, 2026 | 450.9% |
| August 04, 2026 | 465.7% |
| Date | Value |
|---|---|
| August 03, 2026 | 426.4% |
| July 31, 2026 | 404.7% |
| July 30, 2026 | 398.1% |
| July 29, 2026 | 364.8% |
| July 28, 2026 | 339.3% |
| July 27, 2026 | 348.2% |
| July 24, 2026 | 347.3% |
| July 23, 2026 | 331.6% |
| July 22, 2026 | 340.5% |
| July 21, 2026 | 342.5% |
| July 20, 2026 | 336.4% |
| July 17, 2026 | 329.4% |
| July 16, 2026 | 332.4% |
| July 15, 2026 | 344.8% |
| July 14, 2026 | 344.9% |
| July 13, 2026 | 329.2% |
| July 10, 2026 | 320.6% |
| July 09, 2026 | 332.7% |
| July 08, 2026 | 316.0% |
| July 07, 2026 | 309.5% |
| July 06, 2026 | 320.0% |
| July 02, 2026 | 309.3% |
| July 01, 2026 | 347.6% |
| June 30, 2026 | 356.6% |
| June 29, 2026 | 365.7% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Cocrystal Pharma, Inc. | -21.33% |
| CNBX Pharmaceuticals, Inc. | -78.95% |
| GB Sciences, Inc. | 50.00% |
| Arvinas, Inc. | 14.36% |
| Fulcrum Therapeutics, Inc. | -47.46% |